# Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) – FDA Inspection, Mar 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd-laoling-site/5727875a-30a8-41ee-b803-a8c227da1ec2
Source feed: FDA_Inspections

> FDA inspection 1264015 of Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site), March 14, 2025. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264015
- Company Name: Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)
- Inspection Date: 2025-03-14
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1195951 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd-laoling-site/b7268b41-7f73-4392-9cd1-8583ae23caf6)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)

Company: https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd-laoling-site/8ecae9ce-7b8b-40b5-99de-92a6859f9683

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8